Erick J. Lucera
About Erick J. Lucera
Title and Current Role
Erick Lucera serves as the Executive Vice President and Chief Financial Officer. In this capacity, he oversees the financial strategies and operations of the company, ensuring fiscal responsibility and growth. His role includes managing financial planning, risk management, and financial reporting.
Educational Background
Erick Lucera's educational background is extensive and multidisciplinary. He holds a CPH from Harvard University, demonstrating his commitment to further education in public health. He also earned an MS from Boston College, an MBA from Indiana University, and a BS from the University of Delaware. This diverse educational foundation underpins his comprehensive approach to financial management and corporate strategy.
Experience at AVEO Pharmaceuticals
Erick Lucera previously served as Chief Financial Officer at AVEO Pharmaceuticals. In this role, he was responsible for the company's financial planning and strategy, ensuring the alignment of financial operations with corporate objectives. His leadership contributed to AVEO's financial stability and strategic financial initiatives.
Past Roles in Financial Management
Erick Lucera has an extensive background in financial management. He served as Chief Financial Officer for Valeritas, providing financial oversight and strategic planning. As Vice President of Corporate Development at Aratana Therapeutics, he was instrumental in developing corporate strategy and growth initiatives. He also led the healthcare research team at Independence Investments and spent over fifteen years in investment management, including roles at Eaton Vance and as portfolio manager of the Triathlon Life Sciences Fund at Intrepid Capital.
Experience in Investment Management
Erick Lucera spent over fifteen years in investment management. He held roles at Eaton Vance and acted as portfolio manager of the Triathlon Life Sciences Fund at Intrepid Capital. This extensive experience in investment management has equipped him with a deep understanding of financial markets and investment strategies. He also led the healthcare research team at Independence Investments, emphasizing his expertise in healthcare sector investments.